Assessing Stoke Therapeutics: Insights From 6 Financial Analysts
Assessing Stoke Therapeutics: Insights From 6 Financial Analysts
评估Stoke Therapeutics：来自6位金融分析师的见解
6 analysts have expressed a variety of opinions on Stoke Therapeutics (NASDAQ:STOK) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去的一个季度中，有6位分析师对Stoke Therapeutics（纳斯达克股票代码：STOK）表达了不同的观点，从看涨到看跌。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表总结了他们最近的评估，说明了过去30天不断变化的情绪，并将其与前几个月进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for Stoke Therapeutics, presenting an average target of $20.33, a high estimate of $35.00, and a low estimate of $13.00. This upward trend is apparent, with the current average reflecting a 59.45% increase from the previous average price target of $12.75.
在评估12个月目标股价时，分析师公布了对Stoke Therapeutics的见解，将平均目标股价定为20.33美元，最高估计为35.00美元，低估值为13.00美元。这种上升趋势显而易见，当前的平均价格较之前的平均目标价12.75美元上涨了59.45％。
Deciphering Analyst Ratings: An In-Depth...
解密分析师评...
登录免费看全文
登录/注册